Q1 2023 Holdings
Filed 2023-05-15 | 72 holdings | $252.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aerovate Therapeutics Inc | COM | 008064107 | $31.5K | 1,561,696 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $32.5K | 10,813,246 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $38.4K | 1,444,000 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $39.1K | 1,700,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $40.1K | 2,612,115 | 0.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $42.4K | 1,936,133 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $42.6K | 2,800,000 | 0.0% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $49.3K | 1,600,000 | 0.0% |
| Ambrx Biopharma Inc | SPONSORED ADS | 02290A102 | $75.8K | 8,500,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $89.7K | 1,360,000 | 0.0% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $147.4K | 6,892,101 | 0.1% |
| Prometheus Biosciences Inc | COM | 74349U108 | $177.6K | 1,655,000 | 0.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $722.0K | 392,167 | 0.3% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $2.8M | 612,079 | 1.1% |
| Annexon Inc(ANNX) | COM | 03589W102 | $4.8M | 1,250,000 | 1.9% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $5.2M | 1,547,181 | 2.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $7.6M | 700,000 | 3.0% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $10.4M | 296,000 | 4.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $15.1M | 1,821,739 | 6.0% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $18.5M | 300,000 | 7.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $75.6M | 4,557,414 | 29.9% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $110.7M | 3,570,872 | 43.8% |